Baltimore, MDNCT04494295Now EnrollingIRB Ready

Supratentorial Hemorrhage Clinical Trial in Baltimore, MD

Access cutting-edge supratentorial hemorrhage treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Integra LifeSciences Corporation

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access supratentorial hemorrhage specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related supratentorial hemorrhage treatment provided free

Apply for This Baltimore Location

Check if you qualify for this supratentorial hemorrhage clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Supratentorial Hemorrhage Study in Baltimore

This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.

Sponsor: Integra LifeSciences Corporation

Who Can Participate

Inclusion Criteria

Subject Age is \> 18
Subject with a Head CT that demonstrates an acute, spontaneous, primary, supratentorial ICH of volume \> 20 mL, assessed via standard of care techniques
Subject Surgery can be initiated within 24 hours of the last known well time or, in patients with wake-up onset, within 24 hours of the time the patient awoke with symptoms.
Subject has a NIHSS score \> 5
Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 2
Subject with a CT Angiography demonstrating no vascular malformation

Exclusion Criteria

Subject has an underlying vascular lesion defined as causative source of ICH
Subject has a profound neurological deficit defined as fixed/dilated pupils or bilateral extensor motor posturing
Subject has an Infratentorial or brainstem ICH
Subject has a known life expectancy \< 6 months
Subject has an uncorrectable coagulopathy
Subject has a mechanical heart valve
Subject is pregnant
Subject participates in another concurrent interventional clinical trial
Subject who is unable to meet study follow-up requirements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT04494295) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Supratentorial Hemorrhage Treatment Options in Baltimore, MD

If you're searching for supratentorial hemorrhage treatment options in Baltimore, MD, this clinical trial (NCT04494295) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced supratentorial hemorrhage specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all supratentorial hemorrhage clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Baltimore, MD

See all rheumatoid arthritis clinical trials recruiting in Baltimore — not just this study.

Browse Rheumatoid Arthritis Trials in Baltimore →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD